Astragaloside IV-enhanced anti-hepatocarcinoma immunity of dendritic cells

Asian J Surg. 2022 May;45(5):1216-1218. doi: 10.1016/j.asjsur.2022.01.074. Epub 2022 Feb 28.
No abstract available

Keywords: Astragaloside IV; Dendritic cells; Hepatocellular carcinoma; Immunomodulation; Traditional Chinese medicine.

Publication types

  • Letter

MeSH terms

  • Carcinoma, Hepatocellular* / drug therapy
  • Carcinoma, Hepatocellular* / pathology
  • Dendritic Cells / pathology
  • Humans
  • Liver Neoplasms* / drug therapy
  • Liver Neoplasms* / pathology
  • Saponins* / pharmacology
  • Saponins* / therapeutic use
  • Triterpenes* / pharmacology
  • Triterpenes* / therapeutic use

Substances

  • Saponins
  • Triterpenes
  • astragaloside A